• BENZONATATE CHEMBL1374379 FDA ApprovedAntineoplastic

    Alternate Names:

    Benzonatate
    Tessalon
    Zonatuss
    Tesaperl
    104-31-4
    P-Butylaminobenzoic acid omega-O-methylnonaethyleneglycol ester
    Nonaethyleneglycol monomethyl ether P-N-butylaminobenzoate
    Benzononatine
    4-(Butylamino)benzoic acid 3,6,9,12,15,18,21,24,27-nonaoxaoctacos-1-yl ester
    3,6,9,12,15,18,21,24,27-Nonaoxaoctacosyl 4-butylaminobenzoate
    2-[2-[2-[2-[2-[2-[2-[2-(2-Methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 4-butylaminobenzoate
    2,5,8,11,14,17,20,23,26-Nonaoxaoctacosan-28-yl P-(butylamino)benzoate
    DB00868
    MLS002154171
    KM65
    BPBIO1_000049
    LS-36322
    BENZONATATO [INN-SPANISH]
    BENZONATATUM [INN-LATIN]
    SMR001233469
    7699
    DAP000514
    BENZONATATE (USP/INN)
    PRESTWICK0_000012
    PRESTWICK2_000012
    EXANGIT
    3,6,9,12,15,18,21,24,27-NONAOXAOCTACOS-1-YL 4-(BUTYLAMINO)BENZOATE
    NCGC00016362-01
    BSPBIO_000043
    BENZONATATE [USAN:INN:BAN]
    D00242
    C30H53NO11
    2,5,8,11,14,17,20,23,26-NONAOXAOCTACOSAN-28-YL 4-(BUTYLAMINO)BENZOATE
    TESSALON PERLES
    2-[2-[2-[2-[2-[2-[2-[2-(2-METHOXYETHOXY)ETHOXY]ETHOXY]ETHOXY]ETHOXY]ETHOXY]ETHOXY]ETHOXY]ETHYL 4-(BUTYLAMINO)BENZOATE
    TESSALON PERLES (TN)
    P-(N)-BUTYLAMINOBENZOESAEURE-(NONAAETHYLENGLYKOL-MONOMETHYLAETHER)-ESTER
    SPBIO_001964
    BENZOIC ACID, 4-(BUTYLAMINO)-, 2,5,8,11,14,17,20,23,26-NONAOXAOCTACOS-28-YL ESTER
    BENZOIC ACID, 4-(BUTYLAMINO)-, 3,6,9,12,15,18,21,24,27-NONAOXAOCTACOS-1-YL ESTER (9CI)
    POLYETHYLENEGLYCOL-P-N-BUTYLAMINOBENZOATE METHYL ESTER
    9062
    CID7699
    VENTUSSIN-LOZ
    BENZONATATO
    TESSALON-CIBA
    BENZONONANTIN
    AC1Q68HL
    MOLPORT-005-941-702
    EINECS 203-194-7
    BENZOIC ACID, P-(BUTYLAMINO)-, 2-(2-(2-(2-(2-(2-(2-(2-(2-METHOXYETHOXY)ETHOXY)ETHOXY)ETHOXY)ETHOXY)ETHOXY)ETHOXY)ETHOXY)ETHYL ESTER
    HMS1568C05
    BENZOIC ACID, 4-(BUTYLAMINO)-, 3,6,9,12,15,18,21,24,27-NONAOXAOCTACOS-1-YL ESTER
    AC1L1PCL
    VENTUSSIN
    NCGC00016362-02
    P-(N)-BUTYLAMINOBENZOESAEURE-(NONAAETHYLENGLYKOL-MONOMETHYLAETHER)-ESTER [GERMAN]
    PRESTWICK1_000012
    CAS-104-31-4
    CHEBI:3032
    PRESTWICK3_000012
    UNII-5P4DHS6ENR
    TESSALIN
    BENZONATATUM
    AB00513795
    AR-1H9260
    TESALON
    BENZOIC ACID,4-(BUTYLAMINO)-, 3,6,9,12,15,18,21,24,27-NONAOXAOCTACOS-1-YL ESTER
    3,6,9,12,15,18,21,24,27-NONAOXAOCTACOS-1-YL 4-(BUTYLAMINO)BENZOATE #
    NONAETHYLENEGLYCOL-P-N-BUTYLAMINOBENZOATE METHYL ESTER
    I01-9684
    FT-0622718
    LP017037
    BC222308
    NCGC00016362-05
    NCGC00016362-03
    NSC-760128
    CCG-213706
    TOX21_110398_1
    AKOS015891366
    NSC760128
    TOX21_110398
    ZINC3830276
    PHARMAKON1600-01503864
    KM-65
    HMS3373I11
    HMS2230M19
    HMS2095C05
    MAFMQEKGGFWBAB-UHFFFAOYSA-N
    HSDB 7933
    CTK8F7974
    GTPL7611
    BENZONATATE [USP:INN:BAN]
    SCHEMBL28366
    BENZOATE BENZONATATO
    ZONATUSSREG
    TESSALONREG
    BENZONATAT
    DSSTOX_GSID_22655
    DSSTOX_RID_76676
    DSSTOX_CID_2655
    223366032
    VISTUSERTIB
    315661147
    PF-04905428

    Drug Info:

    Drug Categories therapeutic uses
    Drug Categories respiratory system agents
    Drug Categories respiratory system
    Drug Categories pharmacologic actions
    Drug Categories organic chemicals
    Drug Categories cough and cold preparations
    Drug Categories chemical actions and uses
    Drug Categories central nervous system agents
    Drug Categories antitussive agents
    Drug Categories amines
    Drug Groups approved
    Drug Type small molecule
    Year of Approval 1958
    Drug Class antitussive agents
    FDA Approval 1958
    Drug Class small molecule
    Drug Indications Antitussive Agents
    (4 More Sources)